Supposedly, researchers at the University of Queensland have made a significant breakthrough in cancer research. They have identified a new drug target that has the potential to overcome drug resistance and prevent tumor regrowth in cancer patients.
Associate Professor Helmut Schaider from UQ Frazer Institute explained that drug resistance is currently the leading cause of death in cancer patients. For example, almost half of lung cancer patients die from the disease due to tumor regrowth. This issue affects all types of cancer and has adverse outcomes for both patients and the healthcare system.
In an effort to combat drug resistance, an international research project is underway to understand how cancer patients develop this resistance and find suitable targets for intervention. However, success in this area has been limited so far.
Dr. Schaider’s team has identified a molecule that plays a crucial role in allowing cancer cells to regain their ability to proliferate during treatment. This molecule is not currently targeted by any existing treatments, making it a promising candidate for drug development.
To further their research, Dr. Schaider partnered with the Queensland Emory Drug Discovery Initiative (QEDDI), a business unit of UQ commercialization company UniQuest. Together, they are working on developing small molecule inhibitors as new cancer therapies.
Dr Dean Moss, chief executive of UniQuest, expressed his enthusiasm for these collaborative partnerships between UQ researchers and QEDDI. He stated that they are using Dr. Schaider’s expertise in cancer biology along with QEDDI’s drug development capabilities to create new inhibitors that could potentially become effective drugs for treating advanced solid tumors.
This groundbreaking discovery offers hope for improved treatment options for cancer patients who face drug resistance issues. The identification of this new target opens up possibilities for developing innovative drugs that can effectively counteract tumor regrowth and enhance patient outcomes.
The outcome, researchers at the University of Queensland have identified a new drug target with great potential in overcoming drug resistance and preventing tumor regrowth in cancer patients. This discovery brings hope for improved treatment options and better outcomes for those battling cancer.
Supposedly, “Technological Networks,” more information about this breakthrough can be found at https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LnRlY2hub2xvZ3luZXR3b3Jrcy5jb20vY2FuY2VyLXJlc2VhcmNoL25ld3MvdGFyZ2V0LWlkZW50aWZpZWQtd2l0aC1wb3RlbnRpYWwtdG8tb3ZlcmNvbWUtY2FuY2VyLXJlc2lzdGFuY2UtMzc5MDky0gEA?oc=5.
